Kelderman Kim — SEC Form 4 filings
SEC reporting owner CIK 1739054. 19 Form 4 filings on record with FilingPulse; latest filed 2026-09-10.
Transaction summary — filings shown
Covers all 19 filings on record, filed 2024-02-05 to 2026-09-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 13,392 shares, $1,035,013 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 56.
- Largest priced transaction: sale of 11,731 shares @ $77.19 ($905,533) in BIO-TECHNE Corp, filed 2025-01-29.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BIO-TECHNE Corp (TECH) | Chief Executive Officer, Director | 16 | — | 2 legs · 13,392 sh · $1,035,013 | 51 |
| CONMED Corp (CNMD) | Director | 3 | — | — | 5 |
Form 4 filings — Kelderman Kim
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-10 | 4 | CONMED Corp (CNMD) | Option exercise (M): 500 @ $0 · Option exercise (M): 500 (derivative) @ $0 | EDGAR |
| 2026-08-19 | 4 | BIO-TECHNE Corp (TECH) | Grant/award (A): 57,590 (derivative) @ $0 · Grant/award (A): 93,582 (derivative) @ $0 | EDGAR |
| 2026-08-18 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 21,470 @ $0 · Tax withholding (F): 10,821 @ $72.40 · Option exercise (M): 554 (derivative) @ $0 · Disposition to issuer (D): 8,319 (derivative) @ $0 · Disposition to issuer (D): 22,389 (derivative) @ $0 · Option exercise (M): 588 (derivative) @ $0 · +4 more | EDGAR |
| 2026-07-30 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 35,000 @ $47.60 · Tax withholding (F): 28,686 @ $72.07 · Option exercise (M): 35,000 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | CONMED Corp (CNMD) | Grant/award (A): 5,772 (derivative) @ $0 | EDGAR |
| 2026-05-07 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 26,692 @ $47.60 · Tax withholding (F): 23,951 @ $56.68 · Option exercise (M): 26,692 (derivative) @ $0 | EDGAR |
| 2026-04-24 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 11,344 @ $0 · Tax withholding (F): 1,363 @ $58.58 · Option exercise (M): 11,344 (derivative) @ $0 | EDGAR |
| 2026-04-16 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 36,500 @ $0 · Tax withholding (F): 32,088 @ $58.66 · Option exercise (M): 36,500 (derivative) @ $0 | EDGAR |
| 2025-11-05 | 4 | BIO-TECHNE Corp (TECH) | Tax withholding (F): 2,303 @ $62.57 | EDGAR |
| 2025-09-09 | 4 | CONMED Corp (CNMD) | Grant/award (A): 500 (derivative) @ $0 · Grant/award (A): 6,227 (derivative) @ $0 | EDGAR |
| 2025-08-19 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 8,543 @ $0 · Tax withholding (F): 4,305 @ $53.60 · Option exercise (M): 8,543 (derivative) @ $0 · Grant/award (A): 70,708 (derivative) @ $0 · Grant/award (A): 35,354 (derivative) @ $0 · Grant/award (A): 90,441 (derivative) @ $0 | EDGAR |
| 2025-07-24 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 48,176 @ $44.33 · Tax withholding (F): 43,649 @ $53.12 · Option exercise (M): 48,176 (derivative) @ $0 | EDGAR |
| 2025-07-17 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 36,132 @ $44.33 · Tax withholding (F): 32,933 @ $51.42 · Option exercise (M): 36,132 (derivative) @ $0 | EDGAR |
| 2025-01-29 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 13,392 @ $37.70 · Sale (S): 11,731 @ $77.19 · Sale (S): 1,661 @ $77.95 · Option exercise (M): 13,392 (derivative) @ $0 | EDGAR |
| 2024-11-05 | 4 | BIO-TECHNE Corp (TECH) | Tax withholding (F): 2,430 @ $75.31 | EDGAR |
| 2024-09-03 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 1,492 @ $66.97 · Option exercise (M): 1,492 (derivative) @ $0 | EDGAR |
| 2024-08-19 | 4 | BIO-TECHNE Corp (TECH) | Grant/award (A): 51,261 (derivative) @ $0 · Grant/award (A): 25,630 (derivative) @ $0 · Grant/award (A): 69,061 (derivative) @ $0 | EDGAR |
| 2024-08-02 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 14,000 @ $37.70 · Tax withholding (F): 9,479 @ $81.97 · Option exercise (M): 14,000 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | BIO-TECHNE Corp (TECH) | Grant/award (A): 9,423 (derivative) @ $0 · Grant/award (A): 25,945 (derivative) @ $0 · Grant/award (A): 51,890 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1739054 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →